For the first quarter of the April 2027 term, consolidated net sales were 3,225 million yen, operating income was 494 million yen, ordinary income was 342 million yen, and net income attributable to owners of the parent was 302 million yen. YoY, net sales increased by 46.9%, operating income turned to a substantial profit (previous quarter: 9 million yen), ordinary income declined due to foreign exchange losses, and net income attributable to owners of the parent decreased YoY. There is no revision to the full-year projections from the previous release.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7777","jir_company_name":"Ueba Company Name","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/7777-20260910-01.pdf","jir_short_summary":"For the first quarter of the April 2027 term, consolidated net sales were 3,225 million yen, operating income was 494 million yen, ordinary income was 342 million yen, and net income attributable to owners of the parent was 302 million yen. YoY, net sales increased by 46.9%, operating income turned to a substantial profit (previous quarter: 9 million yen), ordinary income declined due to foreign exchange losses, and net income attributable to owners of the parent decreased YoY. There is no revision to the full-year projections from the previous release.","jir_summary":"### Overview of performance\nFor this first quarter, consolidated net sales were 3,225 million yen, up 46.9% YoY. Sales were strong mainly in the US market, with especially large contributions from the GI\/endoscopy area, while the Japanese market declined. Operating income turned to a profit at 494 million yen, but ordinary income was 342 million yen due to foreign exchange losses, and net income attributable to owners of the parent was 302 million yen, down YoY. There is no change to the full-year forecast.\n\n### Outlook and impact for investors\nContinued expansion in the US market and new-area development in Europe are expected, with a corresponding improvement in profitability along with sales growth. However, foreign exchange effects remain a risk to monitor. The company is promoting wider use of PureStat as a wound healing and hemostatic material, and aims to accumulate preclinical and clinical evidence and obtain approvals in the United States.","jir_financial_highlights":"Net sales: 3,225\u767e\u4e07\u5186 (+46.9\uff05)\nOperating income: 494\u767e\u4e07\u5186 (\u524d\u671f\u6bd4+4,?\uff08\u6ce8: 9\u767e\u4e07\u5186\u2192494\u767e\u4e07\u5186\uff09)\nOrdinary income: 342\u767e\u4e07\u5186 (YoY\u25b363.5\uff05)\nNet income attributable to owners of the parent: 302\u767e\u4e07\u5186 (YoY\u25b360.4\uff05)\nTotal assets: 9,401\u767e\u4e07\u5186 (Period-end vs. previous year\u25b3394\u767e\u4e07\u5186)","jir_category":"","jir_hashtags":"#UebaCompanyName, #Financial, #MucosalWoundHealing, #PureStat","jir_key_figures":"Net sales: 3,225 million yen\nOperating income: 494 million yen\nNet income attributable to owners of the parent: 302 million yen","jir_meta_title":"\u3010Ueba Company Name\u3011Q1 FY2027 Financial Results \u2014 Net sales 3,225 million yen, Operating income 494 million yen","jir_meta_description":"Key points of Ueba Company Name's Q1 FY2027 financial results. Net sales 3,225 million yen, operating income 494 million yen, ordinary income 342 million yen, net income 302 million yen. Growth driven by the US market. Full-year forecast unchanged.","jir_og_title":"\u3010Ueba Company Name\u3011Q1 Financial Results Highlights","jir_og_description":"Sales expanding mainly in the United States, full-year forecast unchanged. Focus on exchange rate impact and expansion into new areas.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":56804,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-112371","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n